Pharmaceutical companies have always been criticized for delaying or failing to develop appropriate formulations for HIV drugs. Internal documents of Gilead Sciences, one of the largest pharmaceutical companies in the world, show that it delayed the launch of a promising HIV drug in 2004 with the aim of extending the validity of its patents on a group of successful drugs, according to an investigation by the American New York Times.
2023-07-22 14:04:00
#Report #major #pharmaceutical #company #benefit #delaying #AIDS #treatment
Related posts:
A report revealed that in Argentina 5,000 cases of kidney cancer are diagnosed per year - ADNSUR
Parkinson's Day Treatment at Care Square of Land van Horne: Physical and Psychological Support for P...
Habits that Trigger Heart Disease: Sedentary Lifestyle, Unhealthy Diet, and Smoking
Deterioration of lakes in south-central Chile revealed – Fundación Terram
